Symbols / APLM
APLM Chart
About
Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other solid tumors with MET dysregulation; APL-102, an oral active, small molecule multiple tyrosine kinase inhibitor, which is in a in a Phase 1 clinical trial to inhibit various kinases that are aberrantly activated in cancer cells; and APL-122, a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways that is in Phase 1 dose escalation clinical trials to treat cancers within the brain. Its immuno-oncology product candidates comprise APL-501, APL-502, and APL-801. The company was founded in 2015 and is based in Foster City, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 43.04M |
| Enterprise Value | 20.80M | Income | -31.19M | Sales | 6.93M |
| Book/sh | -3.99 | Cash/sh | 1.90 | Dividend Yield | — |
| Payout | 0.00% | Employees | 13 | IPO | — |
| P/E | — | Forward P/E | -30.89 | PEG | — |
| P/S | 6.21 | P/B | -5.04 | P/C | — |
| EV/EBITDA | -0.79 | EV/Sales | 3.00 | Quick Ratio | 0.91 |
| Current Ratio | 0.97 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -26.64 | EPS next Y | -0.65 | EPS Growth | — |
| Revenue Growth | 3.81% | Earnings | — | ROA | -72.29% |
| ROE | -3.80% | ROIC | — | Gross Margin | 100.00% |
| Oper. Margin | -124.80% | Profit Margin | 0.00% | Shs Outstand | 2.14M |
| Shs Float | 594.13K | Short Float | 0.92% | Short Ratio | 0.91 |
| Short Interest | — | 52W High | 42.12 | 52W Low | 3.66 |
| Beta | 1.78 | Avg Volume | 23.21K | Volume | 6.45K |
| Target Price | — | Recom | None | Prev Close | $21.03 |
| Price | $20.08 | Change | -4.51% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$20.08
Latest analyst target
3. DCF / Fair value
$-121.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$20.08
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-05-08 | main | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-04-01 | main | EF Hutton | Buy → Buy | $7 |
| 2024-04-01 | main | HC Wainwright & Co. | Buy → Buy | $5 |
| 2023-11-20 | reit | HC Wainwright & Co. | Buy → Buy | $17 |
| 2023-10-03 | main | HC Wainwright & Co. | Buy → Buy | $17 |
| 2023-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $18 |
| 2023-06-01 | init | HC Wainwright & Co. | — → Buy | $18 |
| 2023-04-25 | init | EF Hutton | — → Buy | $25 |
- $4.1M PIPE funds Apollomics' reversal of wind‑up to continue global Phase 2 APL‑101 (280+ patients) - Stock Titan Mon, 13 Oct 2025 07
- What's Behind The Big Stock Moves? BDSX, APLM, RNAZ... - Nasdaq Wed, 21 May 2025 07
- Exit Recap: Can APLM ride the EV wave - 2025 Momentum Check & Free Long-Term Investment Growth Plans - baoquankhu1.vn ue, 24 Feb 2026 20
- Nasdaq to resume trading of Apollomics shares after month-long halt - Investing.com ue, 14 Oct 2025 07
- Nasdaq Halts Trading of Apollomics Inc. for Additional Information | NDAQ Stock News - Quiver Quantitative Wed, 17 Sep 2025 07
- Why Apollomics Stock Nosedived 16% After-Hours Today - Stocktwits hu, 16 Oct 2025 07
- Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation - GlobeNewswire Wed, 15 Oct 2025 07
- symbol__ Stock Quote Price and Forecast - CNN hu, 30 Nov 2023 17
- Apollomics Inc. Secures Continued Listing on Nasdaq Following Compliance Determination - Quiver Quantitative Wed, 15 Oct 2025 07
- Apollomics Reports First Half 2025 Financial Results - GlobeNewswire Mon, 22 Dec 2025 08
- Apollomics announces termination of US staff and plans shareholder vote on winding up - Investing.com hu, 28 Aug 2025 07
- APLM Stock Price and Chart — NASDAQ:APLM - TradingView Wed, 24 May 2023 07
- Apollomics Inc. Secures Continued Listing on Nasdaq Following Compliance Notification - Quiver Quantitative Wed, 15 Oct 2025 07
- Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split - Yahoo Finance hu, 21 Nov 2024 08
- Apollomics: Taiwanese-Origin Company With Late Stage Pipeline (NASDAQ:APLM) - Seeking Alpha ue, 29 Aug 2023 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -2.66M | 422.52K | -106.26K | -799.74K |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -40.40M | -173.78M | -239.44M | -91.07M |
| TotalUnusualItems | -12.66M | 2.01M | -506.00K | -2.96M |
| TotalUnusualItemsExcludingGoodwill | -12.66M | 2.01M | -506.00K | -2.96M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -53.86M | -172.60M | -240.81M | -94.80M |
| ReconciledDepreciation | 361.00K | 669.00K | 775.00K | 681.00K |
| EBITDA | -53.06M | -171.77M | -239.94M | -94.03M |
| EBIT | -53.42M | -172.44M | -240.72M | -94.71M |
| NetInterestIncome | 301.00K | 603.00K | 338.00K | 384.00K |
| InterestExpense | 179.00K | 150.00K | 93.00K | 83.00K |
| InterestIncome | 480.00K | 753.00K | 431.00K | 467.00K |
| NormalizedIncome | -43.86M | -174.19M | -240.41M | -92.63M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -53.86M | -172.60M | -240.81M | -94.80M |
| TotalExpenses | 42.03M | 54.37M | 44.39M | 50.27M |
| DilutedAverageShares | 744.00K | 80.45M | 80.45M | |
| BasicAverageShares | 744.00K | 80.45M | 80.45M | |
| DilutedEPS | -231.99 | -2.99 | -1.18 | |
| BasicEPS | -231.99 | -2.99 | -1.18 | |
| DilutedNIAvailtoComStockholders | -53.86M | -172.60M | -240.81M | -94.80M |
| NetIncomeCommonStockholders | -53.86M | -172.60M | -240.81M | -94.80M |
| NetIncome | -53.86M | -172.60M | -240.81M | -94.80M |
| NetIncomeIncludingNoncontrollingInterests | -53.86M | -172.60M | -240.81M | -94.80M |
| NetIncomeContinuousOperations | -53.86M | -172.60M | -240.81M | -94.80M |
| TaxProvision | 259.00K | 10.00K | 1.00K | 1.00K |
| PretaxIncome | -53.60M | -172.59M | -240.81M | -94.80M |
| OtherIncomeExpense | -11.87M | -118.82M | -196.76M | -44.91M |
| OtherNonOperatingIncomeExpenses | 790.00K | -120.84M | -196.25M | -41.95M |
| SpecialIncomeCharges | -13.00M | 0.00 | 0.00 | -3.00M |
| ImpairmentOfCapitalAssets | 13.00M | 0.00 | 0.00 | 3.00M |
| GainOnSaleOfSecurity | 343.00K | 2.01M | -506.00K | 38.00K |
| NetNonOperatingInterestIncomeExpense | 301.00K | 603.00K | 338.00K | 384.00K |
| InterestExpenseNonOperating | 179.00K | 150.00K | 93.00K | 83.00K |
| InterestIncomeNonOperating | 480.00K | 753.00K | 431.00K | 467.00K |
| OperatingIncome | -42.03M | -54.37M | -44.39M | -50.27M |
| OperatingExpense | 42.03M | 54.37M | 44.39M | 50.27M |
| OtherOperatingExpenses | -301.00K | -464.00K | -1.02M | -587.00K |
| ResearchAndDevelopment | 24.57M | 34.19M | 35.46M | 35.57M |
| SellingGeneralAndAdministration | 17.77M | 20.64M | 9.95M | 15.29M |
| GeneralAndAdministrativeExpense | 17.77M | 20.64M | 9.95M | 15.29M |
| OtherGandA | 17.77M | 20.64M | 9.95M | 15.29M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 1.10M | 894.96K | 80.45M | 80.45M |
| ShareIssued | 1.10M | 894.96K | 80.45M | 80.45M |
| TotalDebt | 966.00K | 4.66M | 991.00K | 1.04M |
| TangibleBookValue | 3.13M | 26.48M | -462.90M | -227.66M |
| InvestedCapital | 4.86M | 45.47M | -448.12M | -212.86M |
| WorkingCapital | 2.87M | 26.37M | 43.43M | 85.81M |
| NetTangibleAssets | 3.13M | 26.48M | -462.90M | -227.66M |
| CapitalLeaseObligations | 966.00K | 425.00K | 991.00K | 1.04M |
| CommonStockEquity | 4.86M | 41.23M | -448.12M | -212.86M |
| TotalCapitalization | 4.86M | 41.23M | -448.12M | -212.86M |
| TotalEquityGrossMinorityInterest | 4.86M | 41.23M | -448.12M | -212.86M |
| StockholdersEquity | 4.86M | 41.23M | -448.12M | -212.86M |
| OtherEquityInterest | 35.71M | 23.28M | 10.83M | 9.85M |
| GainsLossesNotAffectingRetainedEarnings | 3.44M | 3.44M | 3.40M | 2.44M |
| OtherEquityAdjustments | 3.44M | 3.44M | 3.40M | 2.44M |
| TreasuryStock | 0.00 | 0.00 | 68.00K | 1.65M |
| RetainedEarnings | -700.82M | -646.97M | -474.60M | -235.44M |
| AdditionalPaidInCapital | 666.53M | 661.47M | 12.28M | 11.89M |
| CapitalStock | 11.00K | 9.00K | 41.00K | 40.00K |
| CommonStock | 11.00K | 9.00K | 41.00K | 40.00K |
| TotalLiabilitiesNetMinorityInterest | 8.23M | 14.15M | 524.60M | 336.30M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 835.00K | 597.00K | 512.24M | 322.74M |
| OtherNonCurrentLiabilities | 511.86M | 322.21M | ||
| PreferredSecuritiesOutsideStockEquity | 0.00 | 511.86M | 322.21M | |
| DerivativeProductLiabilities | 102.00K | 330.00K | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 733.00K | 267.00K | 377.00K | 528.00K |
| LongTermCapitalLeaseObligation | 733.00K | 267.00K | 377.00K | 528.00K |
| CurrentLiabilities | 7.40M | 13.56M | 12.36M | 13.56M |
| OtherCurrentLiabilities | 68.00K | 1.65M | ||
| CurrentDeferredLiabilities | 1.00M | 1.00M | ||
| CurrentDebtAndCapitalLeaseObligation | 233.00K | 4.39M | 614.00K | 508.00K |
| CurrentCapitalLeaseObligation | 233.00K | 158.00K | 614.00K | 508.00K |
| CurrentDebt | 4.24M | |||
| LineOfCredit | 0.00 | 4.24M | 0.00 | |
| PayablesAndAccruedExpenses | 7.17M | 9.16M | 11.68M | 11.40M |
| CurrentAccruedExpenses | 5.92M | 3.19M | 4.14M | 5.39M |
| Payables | 1.25M | 5.97M | 7.54M | 6.01M |
| OtherPayable | 1.25M | 5.97M | 7.54M | 6.01M |
| TotalTaxPayable | 0.00 | |||
| TotalAssets | 13.10M | 55.39M | 76.47M | 123.44M |
| TotalNonCurrentAssets | 2.83M | 15.46M | 20.68M | 24.07M |
| NonCurrentPrepaidAssets | 75.00K | 119.00K | 124.00K | 113.00K |
| InvestmentsAndAdvances | 0.00 | 4.31M | 7.84M | |
| OtherInvestments | 0.00 | 4.31M | 7.84M | |
| GoodwillAndOtherIntangibleAssets | 1.74M | 14.76M | 14.78M | 14.80M |
| OtherIntangibleAssets | 1.74M | 14.76M | 14.78M | 14.80M |
| NetPPE | 1.02M | 586.00K | 1.48M | 1.32M |
| AccumulatedDepreciation | -490.00K | -2.58M | -2.38M | -1.67M |
| GrossPPE | 1.51M | 3.16M | 3.85M | 2.99M |
| Leases | 124.00K | 135.00K | 135.00K | 135.00K |
| MachineryFurnitureEquipment | 403.00K | 455.00K | 852.00K | 488.00K |
| BuildingsAndImprovements | 982.00K | 2.57M | 2.87M | 2.37M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 10.27M | 39.92M | 55.79M | 99.37M |
| CurrentDeferredAssets | 0.00 | 2.25M | ||
| PrepaidAssets | 374.00K | 1.64M | 629.00K | 2.12M |
| Receivables | 127.00K | 466.00K | 547.00K | 506.00K |
| TaxesReceivable | 127.00K | 466.00K | 547.00K | 506.00K |
| CashCashEquivalentsAndShortTermInvestments | 9.77M | 37.82M | 54.61M | 94.48M |
| OtherShortTermInvestments | 0.00 | 5.76M | 21.94M | 47.74M |
| CashAndCashEquivalents | 9.77M | 32.06M | 32.67M | 46.74M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -28.77M | -43.22M | -43.19M | -50.86M |
| RepaymentOfDebt | -5.09M | -444.00K | -593.00K | -528.00K |
| IssuanceOfDebt | 5.75M | 24.48M | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 392.00K | 141.00K | ||
| CapitalExpenditure | -24.00K | -6.00K | -367.00K | -7.55M |
| EndCashPosition | 9.77M | 32.06M | 32.67M | 46.74M |
| BeginningCashPosition | 32.06M | 32.67M | 46.74M | 130.65M |
| EffectOfExchangeRateChanges | 2.00K | 0.00 | 0.00 | |
| ChangesInCash | -22.29M | -619.00K | -14.06M | -83.91M |
| FinancingCashFlow | 468.00K | 21.23M | -294.00K | -1.64M |
| CashFlowFromContinuingFinancingActivities | 468.00K | 21.23M | -294.00K | -1.64M |
| NetOtherFinancingCharges | -2.78M | -1.17M | ||
| InterestPaidCFF | -193.00K | -122.00K | -93.00K | -83.00K |
| ProceedsFromStockOptionExercised | 0.00 | 85.00K | 392.00K | 141.00K |
| CashDividendsPaid | 0.00 | 0.00 | 0.00 | 0.00 |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | 392.00K | 141.00K | ||
| CommonStockIssuance | 392.00K | 141.00K | ||
| NetIssuancePaymentsOfDebt | 661.00K | 24.04M | -593.00K | -528.00K |
| NetShortTermDebtIssuance | -4.22M | 4.24M | 0.00 | 0.00 |
| ShortTermDebtPayments | -4.92M | 0.00 | 0.00 | |
| ShortTermDebtIssuance | 702.00K | 4.24M | 0.00 | 0.00 |
| NetLongTermDebtIssuance | 4.88M | 19.80M | -593.00K | -528.00K |
| LongTermDebtPayments | -170.00K | -444.00K | -593.00K | -528.00K |
| LongTermDebtIssuance | 5.05M | 20.25M | 0.00 | 0.00 |
| InvestingCashFlow | 5.98M | 21.36M | 29.05M | -38.95M |
| CashFlowFromContinuingInvestingActivities | 5.98M | 21.36M | 29.05M | -38.95M |
| NetOtherInvestingChanges | 44.00K | 5.00K | -11.00K | -25.00K |
| InterestReceivedCFI | 198.00K | 821.00K | 431.00K | 467.00K |
| NetInvestmentPurchaseAndSale | 5.76M | 20.49M | 29.00M | -31.84M |
| SaleOfInvestment | 5.76M | 20.49M | 29.00M | 71.95M |
| PurchaseOfInvestment | 0.00 | -103.79M | ||
| NetIntangiblesPurchaseAndSale | 0.00 | 0.00 | -7.50M | |
| PurchaseOfIntangibles | 0.00 | 0.00 | -7.50M | |
| NetPPEPurchaseAndSale | -20.00K | 52.00K | -367.00K | -50.00K |
| SaleOfPPE | 4.00K | 58.00K | 0.00 | 0.00 |
| PurchaseOfPPE | -24.00K | -6.00K | -367.00K | -50.00K |
| OperatingCashFlow | -28.74M | -43.21M | -42.82M | -43.31M |
| CashFlowFromContinuingOperatingActivities | -28.74M | -43.21M | -42.82M | -43.31M |
| TaxesRefundPaid | -259.00K | -10.00K | 56.00K | 0.00 |
| ChangeInWorkingCapital | 1.04M | -3.57M | 6.49M | 2.64M |
| ChangeInPayablesAndAccruedExpense | -571.00K | -2.63M | 2.84M | 3.10M |
| ChangeInPayable | -571.00K | -2.63M | 2.84M | 3.10M |
| ChangeInPrepaidAssets | 1.61M | -932.00K | 3.65M | -453.00K |
| OtherNonCashItems | -5.00K | 44.83M | -338.00K | -384.00K |
| StockBasedCompensation | 10.93M | 12.69M | 3.58M | 8.12M |
| UnrealizedGainLossOnInvestmentSecurities | -222.00K | 74.83M | 189.32M | 37.42M |
| AssetImpairmentCharge | 13.00M | 0.00 | 0.00 | 3.00M |
| DepreciationAmortizationDepletion | 361.00K | 669.00K | 775.00K | 681.00K |
| DepreciationAndAmortization | 361.00K | 669.00K | 775.00K | 681.00K |
| AmortizationCashFlow | 20.00K | 20.00K | 20.00K | 20.00K |
| AmortizationOfIntangibles | 20.00K | 20.00K | 20.00K | 20.00K |
| Depreciation | 341.00K | 649.00K | 755.00K | 661.00K |
| OperatingGainsLosses | 18.00K | -53.00K | -1.90M | |
| GainLossOnInvestmentSecurities | 38.00K | |||
| NetForeignCurrencyExchangeGainLoss | 0.00 | -279.00K | -1.90M | 0.00 |
| GainLossOnSaleOfPPE | 18.00K | 188.00K | 0.00 | 0.00 |
| NetIncomeFromContinuingOperations | -53.60M | -172.59M | -240.81M | -94.80M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for APLM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|